Regeneron Statistic Functions Linear Regression Angle

<div class='circular--portrait' style='background:#800000;color: #F8F8FF;font-size:4em;padding-top: 25px;;'>RP</div>
REGN -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

Regeneron Pharmaceuticals statistic-functions tool provides you with the Statistic Functions execution environment for running Linear Regression Angle function against Regeneron Pharmaceuticals. Regeneron Pharmaceuticals statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.
Symbol
Refresh

The output start index for this execution was two with a total number of output elements of fifty-nine. The Linear Regression Angle indicator plots the angel of the trend line for each Regeneron Pharmaceuticals data point. View also all equity analysis or get more info about linear regression angle statistic functions indicator.

Additional Technical Research

About Regeneron Pharmaceuticals Predictive Technical Analysis

The Macroaxis Predictive Technical Analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Regeneron Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Regeneron Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Regeneron Pharmaceuticals stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Regeneron Pharmaceuticals's daily price indicators and compare them against related drivers such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Regeneron Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Regeneron Pharmaceuticals, we also check how macroeconomic factors affect Regeneron Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
Earnings
Estimates (1)
LowProjected EPSHigh
23.8423.8423.84
Details
Hype
Prediction
LowEstimated ValueHigh
586.26590.29658.39
Details
Intrinsic
Valuation
LowReal ValueHigh
538.91542.94658.39
Details
Naive
Forecast
LowNext ValueHigh
618.24622.27626.31
Details
Analysts
Consensus (21)
LowTarget PriceHigh
400.00559.16734.00
Details
 2017 2018 2019 2020 (projected)
Long Term Debt to Equity0.1144930.0809040.0643750.066069
Interest Coverage82.7989.8773.1768.39
Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York. Regeneron Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 8030 people.

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

Current Thematic Trending

Purchased few shares
Active few hours ago
Purchased few shares
Active few hours ago
Purchased few shares
Active few hours ago
Purchased over 50 shares
Active few hours ago
Purchased few shares
Active few hours ago
Purchased over 60 shares
Active few hours ago
Additionally, take a look at Your Equity Center. Please also try Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page